trial · primary record
Cetuximab
Colorectal Cancer
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2026-10-20 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT06578559 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:52.631Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06578559
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cetuximab · compound